1 documents found
Information × Registration Number 0118U004341, R & D request Title A randomized, double-blind, placebo-controlled study of multiple doses of phase 2b to demonstrate the safety and efficacy of teldrakizumab in patients with psoriatic arthritis in an active dose Head Ждан Вячеслав Миколайович, Registration Date 19-04-2018 Organization Ukrainian medical stomatological Academy popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
A randomized, double-blind, placebo-controlled study of multiple doses of phase 2b to demonstrate the safety and efficacy of teldrakizumab in patients with psoriatic arthritis in an active dose
Head: Ждан Вячеслав Миколайович. A randomized, double-blind, placebo-controlled study of multiple doses of phase 2b to demonstrate the safety and efficacy of teldrakizumab in patients with psoriatic arthritis in an active dose. Ukrainian medical stomatological Academy. № 0118U004341
1 documents found

Updated: 2026-03-22


Роздрукувати цю сторінку